A Study of Induction and Maintenance Treatment With MabThera (Rituximab) in Patients With Indolent B-Cell Nonfollicular Lymphomas
Clinical trial NCT01153971 · COMPLETED
Trial details
- NCT number
- NCT01153971
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-20
- Primary completion
- 2010-09-24
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.